Article
iTRAQ-based quantitative proteomics study on the neuroprotective effects of extract of Acanthopanax senticosus harm on SH-SY5Y cells overexpressing A53T mutant α-synuclein.
Neurochemistry international - 1 Jun 2014
Li Xu-zhao, Zhang Shuai-nan, Wang Ke-xin, Liu Shu-min, Lu Fang
Abstract excerpt
Extract of Acanthopanax senticosus harms (EAS) has been shown to have neuroprotective effects on Parkinson's disease (PD) cell model against α-synuclein overexpression and toxicity. However, studies of its anti-PD mechanism are challenging, owing to the complex pathophysiology of PD, and complexity of EAS with multiple constituents acting on different proteomic pathways. Here, we have investigated the proteomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.